Anti-VCAM-1 nanobodies were developed and conjugated to microbubbles to detect the VCAM-1 expression levels, both in mouse models of atherosclerosis and ex vivo human endarterectomy specimens [131]. This evidence concerns the gene VCAM1 and atherosclerosis.